Overview
Robotic pharmaceutical production company automating biologics manufacturing.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $75M (Series B), Oct 8, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 8, 2026 | $75M · Series B | NantWorks, Patrick Soon-Shiong | 1 source Source ↗ |
Evidence Multiply Labs raises USD 75 million in Series B funding to automate pharmaceutical manufacturing with robotsOn 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 8, 2026 | — · Series B | NantWorks, Patrick Soon-Shiong | 1 source Source ↗ |
Evidence Multiply Labs raises USD 75 million in Series B funding to automate pharmaceutical manufacturing with robotsOn 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
机器人制药生产公司，自动化生物药制造